Loading...

NewGenIvf Group Limited

NIVF•NASDAQ
Healthcare
Medical - Healthcare Plans
$1.80
$0.05(2.86%)

NewGenIvf Group Limited (NIVF) Stock Overview

Explore NewGenIvf Group Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 62.3/100

Key Financials

Market Cap3.3M
P/E Ratio-7.84
EPS (TTM)$-23.04
ROE0.03%
Fundamental Analysis

AI Price Forecasts

1 Week$2.14
1 Month$2.61
3 Months$5.69
1 Year TargetN/A

NIVF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of NewGenIvf Group Limited (NIVF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.86, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.84 and a market capitalization of 3.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
10.15%
5-Day Change
-18.05%
1-Month Change
636.17%
3-Month Change
19.38%
6-Month Change
-26.32%
Year-to-Date (YTD) Change
5.92%
1-Year Change
-56.27%
3-Year Change
-95.53%
5-Year Change
-95.51%
All-Time (Max) Change
-95.51%

Contact Information

https://newgenivf.com
66 2 116 9641
PS Tower, Bangkok, 10110

Company Facts

76 Employees
IPO DateMar 18, 2022
CountryTH
Actively Trading

Frequently Asked Questions

;